Feasibility and Acceptability of a Mobile App for Prolonged Grief Disorder Symptoms.

e-mental health mobile app prolonged grief disorder self-monitoring intervention

Journal

Clinical psychology in Europe
ISSN: 2625-3410
Titre abrégé: Clin Psychol Eur
Pays: Germany
ID NLM: 9918266187206676

Informations de publication

Date de publication:
Mar 2024
Historique:
received: 19 12 2022
accepted: 15 01 2024
medline: 9 8 2024
pubmed: 9 8 2024
entrez: 9 8 2024
Statut: epublish

Résumé

Mobile apps provide a unique platform for mental health assessment and monitoring. They can provide real time, accessible data on symptoms of mental disorders that may yield rich data for detailed clinical assessment and help individuals gain insight into their current mental state. We developed one of the first apps for tracking symptoms of prolonged grief disorder. In this pilot feasibility study, we assess the feasibility and acceptability of a new mobile app mGAGE for use once a day for 3 weeks. 27 participants completed mental health assessments at t1 and t2. Adherence to the app protocol was very high with 100% for the first two weeks of use. A surprising finding was the improvement of grief symptoms at t2. Debriefing interviews revealed general qualitative categories including positive feedback, negative feedback and specific recommendations. Overall, the app was found to be feasible for use for the first two weeks and acceptable for bereaved individuals. This app could provide valuable data for in depth clinical assessment, may support individuals to gain greater insight into their symptoms and may have a therapeutic effect in terms of improved grief symptoms. Implications for future studies including use in larger intervention studies are discussed.

Sections du résumé

Background UNASSIGNED
Mobile apps provide a unique platform for mental health assessment and monitoring. They can provide real time, accessible data on symptoms of mental disorders that may yield rich data for detailed clinical assessment and help individuals gain insight into their current mental state. We developed one of the first apps for tracking symptoms of prolonged grief disorder.
Method UNASSIGNED
In this pilot feasibility study, we assess the feasibility and acceptability of a new mobile app mGAGE for use once a day for 3 weeks. 27 participants completed mental health assessments at t1 and t2.
Results UNASSIGNED
Adherence to the app protocol was very high with 100% for the first two weeks of use. A surprising finding was the improvement of grief symptoms at t2. Debriefing interviews revealed general qualitative categories including positive feedback, negative feedback and specific recommendations. Overall, the app was found to be feasible for use for the first two weeks and acceptable for bereaved individuals.
Conclusions UNASSIGNED
This app could provide valuable data for in depth clinical assessment, may support individuals to gain greater insight into their symptoms and may have a therapeutic effect in terms of improved grief symptoms. Implications for future studies including use in larger intervention studies are discussed.

Identifiants

pubmed: 39119221
doi: 10.32872/cpe.10881
pii: cpe.10881
pmc: PMC11303913
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e10881

Déclaration de conflit d'intérêts

AA, CK, NG and AM report no conflict of interest. Taro Ueno is member of Japanese based startup company, SUSMED inc.

Auteurs

Anaïs Aeschlimann (A)

Department of Psychology, University of Zurich, Zurich, Switzerland.

Nicolas Gordillo (N)

Department of Informatics, University of Zurich, Zurich, Switzerland.

Taro Ueno (T)

SUSMED Inc., Tokyo, Japan.

Andreas Maercker (A)

Department of Psychology, University of Zurich, Zurich, Switzerland.

Clare Killikelly (C)

Department of Psychology, University of Zurich, Zurich, Switzerland.
Department of Psychiatry, University of British Columbia, Vancouver, Canada.

Classifications MeSH